<
 
 
 
 
>
hide
You are viewing a Web site, archived on 20:21:08 Oct 30, 2004. It is now a Federal record managed by the National Archives and Records Administration.
External links, forms, and search boxes may not function within this collection.
U.S. Food and Drug Administration
horizonal rule

Congressional Testimony

2003

November

October

August

July

June

  • William K. Hubbard, June 24, 2003
    Associate Commissioner for Policy, Planning and John M. Taylor, III
    Associate Commissioner for Regulatory Affairs before the Committee on Energy and Commerce, U.S. House of Representative Hearing on“ A System Overwhelmed: The Avalanche of Imported, Counterfeit, and Unapproved Drugs in the U.S.”
  • Daniel E. Troy, June 17, 2003
    Chief Counsel before the Committee on the Judiciary, United States Senate
  • Lester M. Crawford, D.V.M., Ph,D., June 17, 2003
    Deputy Commissioner before the Committee on Agriculture, U.S. House of Representatives
  • William K. Hubbard, June 12, 2003
    Associate Commissioner for Policy, Planning and Legislation before the Committee on Government Reform, U.S. House of Representatives

May

April

March

  • William K. Hubbard, March 27, 2003
    Associate Commissioner for Policy, Planning and Legislation before the Committee on Government Reform, U.S. House of Representatives
  • John M. Taylor, March 10, 2003
    Associate Commissioner for Regulatory Affairs Food and Drug Administration, before the Subcommittee on Oversight and Investigations
    Committee on Energy and Commerce House of Representatives.
  • Mark B. McClellan, M.D., Ph.D., March 6, 2003
    Commissioner of Food and Drug Administration, House Agriculture, Rural Development, FDA and related Agencies Appropriations
    Subcommittee Hearing.

 

Testimony Archive

 

rule link to FDA home page link to U.S. Department of Health and Human Services FDA logo--link to FDA home page